Radiant Innovation

Radiant Innovation Net Debt / EBITDA

The Net Debt to EBITDA of Radiant Innovation (3373.TWO) as of Oct 17, 2026 is -5.52. In the previous year, Net Debt to EBITDA was -4.59 — a change of 20.24% (lower).

Net Debt / EBITDA

-5.52

YoY

20.24%

Last updated:

Net Debt to EBITDA of Radiant Innovation is 2016 -5.52 . Net Debt to EBITDA of Radiant Innovation was 2015 -4.59 . It decreases by 20.24% lower compared to the previous year.

The Radiant Innovation Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2009
-5.14 TWD
Jan 1, 2010
-4.11 TWD
Jan 1, 2011
-7.94 TWD
Jan 1, 2012
-10.53 TWD
Jan 1, 2013
-21.50 TWD
Jan 1, 2014
-14.87 TWD
Jan 1, 2015
-4.59 TWD
Jan 1, 2016
-5.52 TWD
The Radiant Innovation Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
-5.52+20.24%
-4.59-69.14%
-14.87-30.85%
-21.50+104.12%
-10.53+32.65%
-7.94+93.25%
-4.11-20.00%
-5.14-16.94%
-6.18+16.02%
-5.33+480.98%
-0.92—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc., listed on the Taiwan Stock Exchange under ticker 3373.TWO with ISIN TW0003373007, is a company based in Hsinchu, Taiwan. It operates within the Health Care sector, focusing on the design, manufacture, sale, research, and development of infrared technology products. The company went public on October 12, 2004. Radiant Innovation Inc. employs 56 people and offers a range of products including infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed both domestically within Taiwan and internationally across regions such as Asia, the Americas, and Europe. The company's headquarters is located in Hsinchu, a city known for its technology industry. Its website is https://www.radiantek.com.tw/. Radiant Innovation Inc. specializes in health care technology, particularly in devices used for temperature measurement and monitoring, as well as other electronic components relevant to health care applications. The firm's product portfolio reflects a focus on precision and reliability in health care diagnostics and monitoring tools. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Net Debt to EBITDA of Radiant Innovation is -5.52 in 2016.

Net Debt to EBITDA of Radiant Innovation changed from -4.59 to -5.52, representing a 20.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Radiant Innovation

All Key Metrics — Radiant Innovation